Armata Pharmaceuticals (ARMP) Accumulated Depreciation & Amortization (2016 - 2017)
Armata Pharmaceuticals (ARMP) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $1.2 million as the latest value for Q4 2017.
- Quarterly Accumulated Depreciation & Amortization rose 25.54% to $1.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2017, up 25.54% year-over-year, with the annual reading at $1.2 million for FY2017, 25.54% up from the prior year.
- Accumulated Depreciation & Amortization hit $1.2 million in Q4 2017 for Armata Pharmaceuticals, up from $932000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.2 million in Q4 2017 to a low of -$127000.0 in Q4 2014.
- Historically, Accumulated Depreciation & Amortization has averaged $586000.0 across 5 years, with a median of $604000.0 in 2015.
- Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 136.18% in 2014 and later soared 575.59% in 2015.
- Year by year, Accumulated Depreciation & Amortization stood at $351000.0 in 2013, then crashed by 136.18% to -$127000.0 in 2014, then skyrocketed by 575.59% to $604000.0 in 2015, then surged by 54.3% to $932000.0 in 2016, then rose by 25.54% to $1.2 million in 2017.
- Business Quant data shows Accumulated Depreciation & Amortization for ARMP at $1.2 million in Q4 2017, $932000.0 in Q4 2016, and $604000.0 in Q4 2015.